10
Jun
By Michael J. Werner & Sara M. Klock | Holland & Knight
Agency Holds Public Hearing on Cannabis to Gather Input from Stakeholders, Consumers
With the dramatic expansion of CBD products in the market, the U.S. Food and Drug Administration (FDA) is reviewing whether its current regulatory framework is appropriate, and if not, what modifications are needed.
The FDA held a public hearing on May 31, 2019, to gather scientific data and information from various industry stakeholders and consumers about...